These findings suggested that the TGF-β signalling pathway is one of the mechanisms through which MARCKSL1 promotes MVI and the malignant progression of hepatocellular carcinoma, a connection that has not yet been reported and warrants further investigation. This evidence concerns the gene MARCKSL1 and hepatocellular carcinoma.